Latest
News & Updates

The REDDIE project is excited to announce a two-part webinar series focused on advancing the use of real-world data (RWD) in clinical research. These events aim to foster collaboration and spark innovation by connecting researchers, clinicians, data scientists, and other stakeholders across the healthcare data landscape.

Real-world data (RWD) is playing an increasingly vital role in shaping healthcare research and decision-making across Europe. By capturing insights from real-life clinical practice, RWD enhances real-world evidence (RWE), enabling regulatory bodies, policymakers, and researchers to make informed decisions that improve patient outcomes. As the European healthcare landscape evolves, the integration of RWD is crucial for refining treatment guidelines, accelerating innovation, and ensuring that healthcare solutions are tailored to real patient needs. Collaborative efforts like REALM, REDDIE, and other MetReal cluster initiatives are at the forefront of harnessing RWD to support evidence-based policymaking and regulatory advancements.

Every 14 November, World Diabetes Day shines a spotlight on diabetes mellitus through a global campaign led by the International Diabetes Federation. With each year’s campaign focusing on a specific theme, 2024 centres on well-being. In alignment with this theme, the portfolio of diabetes projects at Eurice and its sister company RISE have launched a collaborative campaign to raise awareness and emphasise the common goal of all projects: improving the daily lives and experiences of people living with diabetes.

REDDIE – Real-world evidence for decisions in diabetes is an EU-funded initiative that aims to explore how real-world data can complement randomised controlled trials to improve the efficacy, safety, and value for money of technologies to prevent and treat diabetes.